Novast Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NOVAST LABS, and what generic and branded alternatives to NOVAST LABS drugs are available?
NOVAST LABS has eighty-four approved drugs.
There are three tentative approvals on NOVAST LABS drugs.
Drugs and US Patents for Novast Labs
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novast Labs | TRIAZOLAM | triazolam | TABLET;ORAL | 214219-001 | Oct 20, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Novast Labs | CLINDAMYCIN PHOSPHATE | clindamycin phosphate | SOLUTION;TOPICAL | 064108-001 | Sep 27, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Novast Labs | CLOBETASOL PROPIONATE | clobetasol propionate | AEROSOL, FOAM;TOPICAL | 206805-001 | Jul 31, 2017 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Novast Labs | GEMCITABINE HYDROCHLORIDE | gemcitabine hydrochloride | INJECTABLE;INJECTION | 210383-003 | Feb 14, 2019 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.